Its portfolio includes pandemic influenza vaccine in Phase III, a pseudomonas vaccine
in Phase II/III and a tuberculosis vaccine in Phase II.
The UBS experts see the development of the new pseudomonas vaccine
in partnership with Swiss drug maker Novartis (VTX:NOVN) as a propeller for Intercell's financial figures.
The company's pipeline includes a Travelers' Diarrhea Vaccine Patch (Phase III in preparation), a Pseudomonas vaccine
candidate (Phase II), a Vaccine Enhancement Patch to prevent Pandemic Influenza in combination with an injected vaccine (Phase II), a vaccine program for S.
We hope to get the pseudomonas vaccine
here soon - the initial trials seem promising.